References
Tan E, Gouvas N, Nicholls RJ, Ziprin P, Xynos E, Tekkis PP (2009) Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer. Surg Oncol 18(1):15–24
Albanopoulos K, Armakolas A, Konstadoulakis M, Leandros E, Tsiobanou E, Katsaragakis S, Alexious D, Androulakis G (2000) Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer. Am J Gastroenterol 95(4):1056–1061
Mintz PJ, Kim J, Do KA et al (2003) Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat Biotechnol 21:57–63
Lee AS (2007) GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res 67(8):3496–3499
Scanlan M, Chen Y, Williamson B, Gure A, Stockert E, Gordan H, Tureci O, Sahin Y, Pfreundshuh M, Old L (1998) Characterization of human colon cancer antigen recognized by autologous antibodies. Int J Cancer 76:652–658
Fujita Y, Nakanishi T, Miyamoto Y, Hiramatsu M, Mabuchi H, Miyamoto A, Shimizu A, Takubo T, Tanigawa N (2008) Proteomics-based identification of autoantibody against heat hock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma. Cancer Lett 263:280–290
De Monte L, Sanvito F, Olivieri S, Vigano F, Doglioni C, Frason M, Braga M, Bachi A, Dellaona P, Pia Protti M, Alessio M (2008) Serological immunoreactivity against colon cancer proteome varies upon disease progression. J Prot Res 7:504–514
Nam M, Madoz-Gurpide J, Wang H, Lescure P, Schmalbach C, Zhao R, Misek D, Kuick R, Brenner D, Hanash S (2003) Molecular profiling of the immune response in colon cancer using protein microarrays: occurrence of autoantibodies to ubiquitin C-terminal hydrolase L3. Proteomics 3:2108–2115
Ran Y, Hu H, Zhou Z, Yu L, Sun L, Pan J, Liu J, Yang Z (2008) Profiling tumor-associated autoantibodies for the detection of colon cancer. Clin Cancer Res 14(9):2696–2700
Mou Z, He Y, Wu Y (2009) Immunoproteomics to identify tumor-associated antigens eliciting humoral response. Cancer Lett 278:123–129
Tanaka S, Sakai A, Kimura K, Yoshida H, Fushitani H, Ogata A, Miyamoto A, Fukushima M, Wada A, Tanigawa N (2008) Proteomic analysis of the basic proteins in 5-fluorouracil resistance of human colon cancer cell line using the radical-free and highly reducing method of two-dimensional polyacrylamide gel electrophoresis. Int J Oncol 33(2):361–370
Brichory F, Misek D, Yim A, Krause M, Giordano T, Beer D et al (2001) An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci USA 98:9824–9829
Kawasaki H, Toyoda H, Shinohara H, Okuda J, Watanae T, Yamamoto T et al (2001) Expression of surviving correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumoigenesis. Cancer 91:2026–2032
Nogales E (2000) Structural insites into microtubule function. Ann Rev Biochem 69:277–302
Sullivan KF (1998) Structure and utilization of tubulin isotypes. Ann Rev Cell Biol 4:687–716
Luduena RF (1998) Multiple forms of tubulin: different gene products and covalent modifications. Int Rev Cytol 178:207–275
Yeh IT, Luduena RF (2004) The βII isotype of tubulin is present in the cell nuclei of a variety of cancers. Cell Motil Cytoskeleton 57:96–106
Jouhilahti EM, Peltonon S, Peltonen J (2008) Class III beta-tubulin is a component of the mitotic spindle in multiple cell types. J Histochem Cytochem 56(12):113–119
Desai A, Mitchison TJ (1997) Microtubule polymerization dynamics. Ann Rev Cell Dev Biol 13:83–117
Scott CA, Walker CC, Neal DA, Harper CE, Bloodgood RA, Somers KD, Mills SE, Rebhun LI, Levine PA (1990) Beta-tubulin epitope expression in normal and malignant epithelial cells. Arch Otolaryngol Head Neck Surg 116(5):583–589
Ferrandina G, Zannoni GF, Martinelli E, Praglia A, Gallotta V, Mozzetti S, Scambia G, Ferlini C (2006) Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients. Clin Cancer Res 12(9):2774–2779
Katsetos CD, Kontogeorgos G, Geddes JF, Herman MM, Tsimara-Papastamatious H, Yu Y, Sakkas LI, Tsokos M, Patchefsky AS, Ehya H, Cooper HS, Provencio J, Spano AJ, Frankfurter A (2000) Differential distribution of the neuron-associated class III beta-tubulin in neuroendocrine lung tumors. Arch Pathol Lab Med 124(4):535–544
Roh JY, Kee SH, Choi JW, Lee JH, Lee JH, Lee ES, Kim YS (2007) Expression of class II beta-tubulin in non-melanoma cutaneous tumors. J Cutan Pathol 34(2):166–173
Ranganathan S, Salazar H, Benetatos CA, Hudes GR (1997) Immunohistochemical analysis of beta-tubulin isotypes in human prostate carcinoma and benign prostatic hypertrophy. Prostate 30(4):263–268
Jirasek T, Cipro S, Musilova A, Kubecova M, Mandys V (2009) Expression of class III β-tubulin in colorectal carcinomas: an immunohistochemical study using TU-20 and TuJ-1 antibody. Indian J Med Res 129:89–94
Giarnieri E, De Francesco GP, Carico E, Midiri G, Amanti C, Giacomelli L, Tucci G, Gidaro S, Stroppa I, Gidaro G, Giovagnoli MR (2005) Alpha- and beta-tubulin in rectal cancer development. Anticancer Res 25(5):3237–3241
Hiser L, Aggarwal A, Young R, Frankfurter A, Spano A, Correia J, Lobert S (2006) Comparison of β-tubulin mRNA and protein levels in 12 human cancer cell lines. Cell Motil Cytoskeleton 63:41–52
Gan P, Pasquier E, Kavallaris M (2007) Class III β-tubulin mediates sensitivity to chemotherapeutic drugs in non-small cell lung cancer. Cancer Res 67(19):9356–9363
Kim JS, Lee YC, Nam HT, Li G, Yun EJ, Song KS, Seo KS, Park JH, Ahn JW, Zee OP, Park JI, Yoon WH, Lim K, Hwant BD (2007) Apicularen A induces cell death through Fas ligand up-regulation and microtubule disruption by tubulin down-regulation in HM7 human colon cancer cells. Clin Cancer Res 13(21):6509–6517
Jalbout M, Jrad B, Bouaouina N, Gargouri J, Yacoub S, Zakhama A, Khlifa R, Chouchane L (2002) Autoantibodies to tubulin are specifically associated with the young age onset of the nasopharyngeal carcinoma. Int J Cancer 101:146–150
Prasannan L, Misek D, Hinderer R, Michon J, Geiger J, Hanash S (2000) Identification of β-tubulin isoforms as tumor antigens in neuroblastoma. Clin Cancer Res 6:3949–3956
Hamrita B, Chahed K, Kabbage M, Guillier C, Trimeche M, Chaieb A, Chouchane L (2008) Identification of tumor antigens that elicit a humoral immune response in breast cancer patients’ sera by serological proteome analysis (SERPA). Clin Chim Acta 393(2):95–102
Shukla S, Pranay A, D’Cruz AK, Chaturvedi P, Kane SV, Zingde SM (2009) Immunoproteomics reveals that cancer of the tongue and the gingivobuccal complex exhibit differential autoantibody response. Cancer Biomark 5(3):127–135
Svarcová J, Fialová L, Bartos A, Steinbachová M, Malbohan I (2008) Cerebrospinal fluid antibodies to tubulin are elevated in the patients with multiple sclerosis. Eur J Neurol 15(11):1173–1179
Bansal D, Herbert F, Lim P, Deshpande P, Bécavin C, Guiyedi V, de Maria I, Rousselle JC, Namane A, Jain R, Cazenave PA, Mishra GC, Ferlini C, Fesel C, Benecke A, Pied S (2009) IgG autoantibody to brain beta tubulin III associated with cytokine cluster-II discriminate cerebral malaria in Central India. PLoS One 4(12):e8245
Zou J, Yu XF, Bao ZJ, Dong J (2011) Proteome of human colon cancer stem cells: a comparative analysis. World J Gastroenterol 17(10):1276–1285
Juwana J, Henderikx P, Mischo A, Wadle A, Fadle N, Gerlach K, Arends J, Hoogenboom H, Pfreundschuh M, Renner C (1999) EB/RP gene family encodes tubulin binding proteins. Int J Cancer 81(2):275–284
Carles G, Braguer D, Dumontet C, Bourgarel V, Goncalves A, Sarrazin M, Rognoni J, Briand C (1999) Differentiation of human colon cancer cells changes the expression of beta-tubullin isotypes and MAPs. Br J Cancer 80(8):1162–1168
Acknowledgments
We thank Dr. Takashi Nirasawa (Bruker Daltonics Japan, Yokohama) for helpful technical supports of the MALDI-MS analysis. This work was supported by a 2008–2010 Grant-in-Aid for Scientific Research (21790545) from the Ministry of Education, Science and Culture of Japan.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in the special issue Biomedical Mass Spectrometry with guest editors Hisao Oka and Mitsutoshi Setou.
Rights and permissions
About this article
Cite this article
Bouras, G., Nakanishi, T., Fujita, Y. et al. Identification of β-tubulin as a common immunogen in gastrointestinal malignancy by mass spectrometry of colorectal cancer proteome: implications for early disease detection. Anal Bioanal Chem 403, 1801–1809 (2012). https://doi.org/10.1007/s00216-011-5628-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-011-5628-5